Resonium-A
Resonium-A is a medicine authorised by Swissmedic under authorisation number 33379. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 22 April 1968 and the authorisation is valid without a time limit. ATC code V03AE01 places the medicine in the group All other therapeutic products.
| Authorisation number | 33379 |
|---|---|
| Name | Resonium-A |
| Full name | Resonium-A, poudre |
| Authorisation holder | Sanofi-Aventis (Suisse) SA |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | V03AE01 |
| First authorisation | 22 April 1968 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Resonium-A, poudre | B | 22 April 1968 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 13 | 450 | g | V03AE01 | 16.00.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Resonium-A authorised in Switzerland?
Yes. Resonium-A is authorised by Swissmedic under authorisation number 33379, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Resonium-A have?
Resonium-A is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Resonium-A?
The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.